Lifeward Ltd. LFWD
Nasdaq · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2014-09-12
Lifeward Ltd. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $22.0M | $25.7M | $13.9M | $5.5M | $6.0M | $4.4M | $4.9M | $6.5M | $7.8M | $5.9M |
| Gross profit | $8.4M | $8.2M | $4.5M | $1.9M | $2.9M | $2.2M | $2.7M | $2.8M | $3.1M | $736,000 |
| R&D expense | $3.2M | $4.6M | $4.1M | $4.0M | $2.9M | $3.5M | $5.3M | $7.3M | $6.0M | $9.0M |
| Operating income | -$19.7M | -$29.3M | -$23.6M | -$19.1M | -$12.7M | -$12.0M | -$14.0M | -$19.2M | -$22.0M | -$30.4M |
| Income tax | -$55,000 | $43,000 | -$12,000 | $467,000 | $94,000 | $51,000 | $7,000 | -$5,000 | $119,000 | $3,000 |
| Net income | -$19.9M | -$28.9M | -$22.1M | -$19.6M | -$12.7M | -$13.0M | -$15.6M | -$21.7M | -$24.7M | -$32.5M |
| EPS (diluted) | $-17.16 | $-39.96 | $-0.37 | $-0.31 | $-0.27 | $-0.82 | — | — | — | — |
| Operating cash flow | -$16.8M | -$21.7M | -$20.7M | -$17.9M | -$11.5M | -$12.6M | -$14.8M | -$14.8M | -$22.5M | -$27.5M |
| Free cash flow | -$16.8M | -$21.7M | -$20.7M | -$17.9M | -$11.5M | -$12.7M | -$14.8M | -$14.8M | -$22.5M | -$28.0M |
| Cash & equivalents | $2.2M | $6.7M | $28.1M | $67.9M | $88.3M | $20.4M | $16.3M | $9.5M | $14.6M | $23.7M |
| Inventory | $5.7M | $6.7M | $5.7M | $2.9M | $3.0M | $3.5M | $3.1M | $2.2M | $3.6M | $3.3M |
| Total assets | $22.9M | $30.5M | $63.2M | $74.2M | $94.8M | $28.1M | $24.4M | $15.0M | $22.9M | $31.8M |
| Total liabilities | $14.5M | $11.6M | $16.7M | $6.1M | $5.4M | $6.3M | $13.6M | $13.0M | $19.2M | $23.5M |
| Shareholders' equity | $8.4M | $18.8M | $46.5M | $68.2M | $89.4M | $21.8M | $10.8M | $1.9M | $3.7M | $8.3M |
Growth · year-over-year · Revenue CAGR 15.8%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -14.1% | +85.2% | +151.4% | -7.6% | +35.8% | -9.9% | -25.5% | -15.6% | +32.1% | +56.7% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.